Cell-specific temporal infection of the brain in a simian immunodeficiency virus model of human immunodeficiency virus encephalitis

被引:12
|
作者
Thompson, Katherine A. [1 ,2 ]
Varrone, John J. [3 ]
Jankovic-Karasoulos, Tanja [1 ,2 ]
Wesselingh, Steven L. [2 ,4 ]
McLean, Catriona A. [1 ,2 ]
机构
[1] Alfred Hosp, Dept Anat Pathol, Melbourne, Vic 3004, Australia
[2] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia
[3] Johns Hopkins Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD USA
[4] Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic, Australia
基金
英国医学研究理事会;
关键词
human immunodeficiency virus; simian immunodeficiency virus encephalitis; neuropathogenesis; laser microdissection; CENTRAL-NERVOUS-SYSTEM; LASER CAPTURE MICRODISSECTION; ACTIVE ANTIRETROVIRAL THERAPY; PERIVASCULAR MACROPHAGES; HIV-INFECTION; NEUROVIRULENT SIV; MANNOSE RECEPTOR; AIDS DEMENTIA; IN-VITRO; ASTROCYTES;
D O I
10.1080/13550280903030125
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Increasing evidence supports early brain infection by human immunodeficiency virus (HIV). Definitive temporal studies determining when and within which brain cells viral DNA is present are lacking. This study utilized simian immunodeficiency virus (SIV)-infected macaques sacrificed at days 10, 21, 56, and 84 post inoculation. Laser-microdissection isolated pure perivascular macrophage, parenchymal microglia, and astrocyte populations. Nested polymerase chain reaction (PCR) and sequencing determined the presence and characteristics of SIV V3 and V1 env DNA from each population. At day 10, SIV DNA was detected in perivascular macrophage and astrocytes but not parenchymal microglia. gp41 expression was restricted to perivascular macrophage. At day 21, SIV DNA was not detected in any cell type. At day 56, SIV DNA was detectable in perivascular macrophage from one of two macaques, with no gp41 expression detected. At day 84 (morphologic and clinical encephalitis), SIV DNA was detected in all cell types, gp41 was only detected in perivascular macrophage and parenchymal microglia. The neurovirulent molecular clone, SIV/17E-Fr, was the only genotype identified in the brain cell populations. Early, productive brain SIV infection was transient and restricted to trafficking perivascular macrophage. During the nonencephalitic stage, there was a period of time when no SIV DNA could be detected in the brain cell populations. SIV was then seen to reenter the brain via infected perivascular macrophage, leading to productive infection of brain parenchymal macrophage/microglia with a terminal phase of encephalitis. These data challenge current notions of a HIV reservoir within latently infected, semipermanent brain cells and has significant implications for the timing and design of therapies to prevent HIV encephalitis (HIVE). Journal of NeuroVirology (2009) 15, 300-311.
引用
收藏
页码:300 / 311
页数:12
相关论文
共 50 条
  • [41] Impact of fluctuation in frequency of human immunodeficiency virus/simian immunodeficiency virus reactivation during antiretroviral therapy interruption
    Wu, Yuhuang
    Pinkevych, Mykola
    Xu, Zhuang
    Keele, Brandon F.
    Davenport, Miles P.
    Cromer, Deborah
    PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2020, 287 (1933)
  • [42] Psychosocial Stress Alters the Immune Response and Results in Higher Viral Load During Acute Simian Immunodeficiency Virus Infection in a Pigtailed Macaque Model of Human Immunodeficiency Virus
    Guerrero-Martin, Selena M.
    Rubin, Leah H.
    Mcgee, Kirsten M.
    Shirk, Erin N.
    Queen, Suzanne E.
    Li, Ming
    Bullock, Brandon
    Carlson, Bess W.
    Adams, Robert J.
    Gama, Lucio
    Graham, David R.
    Zink, Christine
    Clements, Janice E.
    Mankowski, Joseph L.
    Pate, Kelly A. Metcalf
    JOURNAL OF INFECTIOUS DISEASES, 2021, 224 (12) : 2113 - 2121
  • [43] Cerebrospinal Fluid Biomarkers of Simian Immunodeficiency Virus EncephalitisCSF Biomarkers of SIV Encephalitis
    Stephanie J. Bissel
    Julia Kofler
    Julia Nyaundi
    Michael Murphey-Corb
    Stephen R. Wisniewski
    Clayton A. Wiley
    Journal of Neuroimmune Pharmacology, 2016, 11 : 332 - 347
  • [44] Public health and eradication of infection by the Human Immunodeficiency Virus
    Verdejo Ortes, Jose
    REVISTA ESPANOLA DE SALUD PUBLICA, 2019, 93
  • [45] Ocular surface neoplasias and human immunodeficiency virus infection
    Weinstein, Jessica E.
    Karp, Carol L.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2013, 26 (01) : 58 - 65
  • [46] Dyslipidemia and Cardiovascular Risk in Human Immunodeficiency Virus Infection
    Kelesidis, Theodoros
    Currier, Judith S.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2014, 43 (03) : 665 - +
  • [47] Systemic Preexposure Prophylaxis for Human Immunodeficiency Virus Infection
    Romanelli, Frank
    Murphy, Brian
    PHARMACOTHERAPY, 2010, 30 (10): : 1021 - 1030
  • [48] Enhancing immune restoration in human immunodeficiency virus infection
    Sahali, S.
    Carcelain, G.
    Goujard, C.
    Delfraissy, J. -F.
    Ghosn, J.
    REVUE DE MEDECINE INTERNE, 2011, 32 (07): : 425 - 431
  • [49] Variation of Human Immunodeficiency Virus Type-1 Reverse Transcriptase within the Simian Immunodeficiency Virus Genome of RT-SHIV
    Wadford, Debra A.
    Kauffman, Robert C.
    Deere, Jesse D.
    Aoki, Scott T.
    Stanton, Richard A.
    Higgins, Joanne
    Van Rompay, Koen K. A.
    Villalobos, Andradi
    Nettles, James H.
    Schinazi, Raymond F.
    Pedersen, Niels C.
    North, Thomas W.
    PLOS ONE, 2014, 9 (01):
  • [50] Human Immunodeficiency Virus Infection And Hypertension. Is There a Connection?
    Sanidas, Elias
    Papadopoulos, Dimitris P.
    Velliou, Maria
    Tsioufis, Kostas
    Barbetseas, John
    Papademetriou, Vasilios
    AMERICAN JOURNAL OF HYPERTENSION, 2018, 31 (04) : 389 - 393